Price Chart

Profile

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.
URL https://www.biontech.de
Investor Relations URL https://investors.biontech.de/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 27, 2024 (est.)
Last Earnings Release Nov. 06, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 02, 2022

Profile

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.
URL https://www.biontech.de
Investor Relations URL https://investors.biontech.de/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 27, 2024 (est.)
Last Earnings Release Nov. 06, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Jun. 02, 2022